Clinical trial
A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple…
NCT00241371 · Washington University School of Medicine, Other · Terminated
Key facts
| NCT number | NCT00241371 |
|---|---|
| Title | A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma |
| Official title | A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma |
| Lead sponsor | Washington University School of Medicine, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Clofarabine |
| Enrollment | 8 |
| Start date | Mar 1, 2005 |
| Primary completion | Nov 1, 2005 |
| Completion | Dec 1, 2007 |
| First posted | Oct 18, 2005 |
| Last update posted | Aug 13, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: